---
title: "SNY.US (SNY.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/SNY.US/news.md"
symbol: "SNY.US"
name: "SNY.US"
parent: "https://longbridge.com/zh-CN/quote/SNY.US.md"
datetime: "2026-03-15T22:41:51.272Z"
locales:
  - [en](https://longbridge.com/en/quote/SNY.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SNY.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SNY.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/SNY.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/SNY.US/news.md)


# SNY.US (SNY.US) — 相关新闻

### [XY Capital Ltd Acquires Shares of 33,970 Sanofi $SNY](https://longbridge.com/zh-CN/news/279122080.md)
*2026-03-14T11:53:15.000Z*
> XY Capital Ltd has acquired 33,970 shares of Sanofi (NASDAQ:SNY) valued at approximately $1.6 million, as reported in it

### [According to reports, the biotech startup Earendil Labs is seeking to raise HKD 3.9 billion for its listing in Hong Kong](https://longbridge.com/zh-CN/news/279115069.md)
*2026-03-14T08:10:37.000Z*
> Biotechnology startup Earendil Labs plans to go public in Hong Kong, expecting to raise up to $500 million (approximatel

### [Biotech startup Earendil Labs is reported to raise HKD 3.9 billion through a Hong Kong IPO for AI drug development, collaborating with Sanofi and WuXi AppTec](https://longbridge.com/zh-CN/news/279104596.md)
*2026-03-14T01:35:35.000Z*
> Biotechnology startup Earendil Labs plans to go public in Hong Kong, aiming to raise up to $500 million (approximately H

### [Artificial intelligence-driven biotechnology company Earendil Labs is reportedly considering an IPO in Hong Kong](https://longbridge.com/zh-CN/news/279052500.md)
*2026-03-13T13:26:08.000Z*
> The AI-driven biotechnology company Earendil Labs is considering an IPO in Hong Kong, with a fundraising scale potential

### [Sanofi: Information concerning the total number of voting rights and shares - February 2026](https://longbridge.com/zh-CN/news/278924311.md)
*2026-03-12T17:31:05.000Z*
> Details regarding the complete count of voting rights and shares, as mandated by article L. 233-8 II of the French Comme

### [How New CHMP Opinions on Dupixent and Acoziborole Will Impact Sanofi (ENXTPA:SAN) Investors](https://longbridge.com/zh-CN/news/278666481.md)
*2026-03-11T06:22:26.000Z*
> In February 2026, Sanofi and Regeneron received positive CHMP opinions for Dupixent in young children with chronic spont

### [Brazil drugmaker EMS eyes overseas deals after buying Sanofi unit](https://longbridge.com/zh-CN/news/278609745.md)
*2026-03-10T20:12:22.000Z*
### [Sanofi Wins Japan Orphan Status for Rilzabrutinib and Moves to Strengthen Governance](https://longbridge.com/zh-CN/news/278578865.md)
*2026-03-10T14:57:45.000Z*
> Sanofi Wins Japan Orphan Status for Rilzabrutinib and Moves to Strengthen Governance

### [P/E Ratio Insights for Sanofi](https://longbridge.com/zh-CN/news/278419986.md)
*2026-03-09T16:00:35.000Z*
> Sanofi Inc. (NASDAQ:SNY) is currently trading at $43.87, down 1.54%. The stock has decreased by 9.80% over the past mont